and c.299-300delAT/c.580G>A in GJB2/GJB3 were found in three
| PATIENTS AND ME THODS
The institutional review board of the First Affiliated Hospital, Sun Yat-sen University approved our study. Informed consent had been obtained from parents or their guardians prior to this study.
| Study participants, PCR, Sanger sequencing
A total of 100 peripheral blood DNA samples with mono-allelic GJB2 mutations were collected from our Chinese NSHI hereditary database (Table 1) . Temporal imaging and auditory assessments with auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) in each participant had ruled out the risk of enlarged vestibular aqueduct or auditory neuropathy. No other known etiology was found, nor had these samples been studied in prior report. 13 Common mutations in SLC26A4 or mitochondrial genes were previously excluded. Also, neither the splice site mutation c. IVS1 + 1G>A, nor defects in exon 1 and its basal promoter in GJB2 was present.
DNA fragments spanning the GJB2, GJB3 and GJB6 coding exons were amplified by PCR methods (GJB2: Forward primer:
TTGGTGTTTGCTCAGGAAGA; Reverse primer: GGCCTACAG GGGTTTCAAAT; GJB3: Forward primer: TACGATGGTTTTTCC TCTAATTCT; Reverse primer: TTGCATAACTTAGTGAACTCAGAG; GJB6: Forward primer: TATCACCGTGTCACTTTCC; Reverse primer: CAGGTTGGTATTGCCTTC). Two large deletions in GJB6 were also tested as previously described. 7, 9 PCR with a volume of 25 μL, containing 100 ng DNA template, 5pmol of each primer, 12.5 μL 2X PCR buffer mixtures and ddH 2 O, were conducted with an annealing temperature 56°C. The products were purified and sequenced by Sanger sequencing using a 3730XL DNA analyzer (Applied Biosystems, Carlsbad, California, USA).
| Targeted NGS in GDHY-family
We extended our study by using targeted deafness genes capture and NGS on samples III:2 from the family-GDHY to explore other hidden modified alleles. The designed panel covers all coding exons, splice sites and flanking intron sequences of 127 known deafness genes including 20 autosomal dominant NSHI (DFNA) genes, 30 autosomal recessive NSHI (DFNB) genes, six DFNA/DFNB genes, three X-linked deafness genes, two maternally inherited deafness genes, 11 syndromic/non-syndromic deafness genes, and 55 syndromic deafness genes (Table S1 ). The captured regions were analyzed using illumina Hiseq2000 platform. Variants detected with >0.05 frequency in 1000 Genome, dbSNP, and Hapmap and >0.3 in YH database 14 were filtered. The identified mutations were further confirmed in the family members by Sanger sequencing as described above.
| In silico analysis
Multiple sequence alignments were completed with ClustalX2. We used SIFT, Polyphen-2, MutationTaster to evaluate possible pathogenicity. The crystalline structure of human CX31 (GJB3) was applied with its closest homologous protein family member, human CX26 (GJB2), which has been elucidated by crystallography (PDB entry 2ZW3) to a resolution of 3.5A°. Three-dimensional modeling of human wild-type CX26 and CX31, CX26-p.L213S, and CX31-p.
V84I mutations was performed using SWISS-MODEL, an automated homology modeling program. 15 
| RE SULTS
The basic information of this cohort was summarized in Table 1 .
Overall, one missense mutation c.250G>A (p.Val84Ile, 1/100) and one synonymous variant c.357T>C (rs41310442, p.Asn119=, 12/100) in GJB3 exon 2 were finally detected in these unrelated families. The c.357T>C was classified as benign and its pathogenicity remains disputable, since synonymous variant may result in hearing loss as well. 16 Though the variant c.250G>A was classified as polymorphism in previous report, 17 deleterious effect in cellular level induced by this variant strongly debated its "Benign" significance. 18 This yielded a putative mutational rate of 1% in GJB2/GJB3 genes responsible for NSHI in this cohort. Additionally, we failed to identify any potentially suspected allele in GJB6 gene.
The GJB3 c.250G>A was identified in the GDHY-family (Figure 1 ).
The propositus (II:2) had congenital bilateral moderate hearing loss and was found to carry a novel GJB2 missense mutation c.638T>C The allelic frequency of GJB3 mutation p.V84I is estimated to be 0.25% among Chinese NSHI, 13 and 0.0037 in 1000 Genome.
| D ISCUSS I ON
Despite the fact that the biallelic mutations in GJB2 p.V37I/p.L213S
were predicted to cause sufficient connexin dysfunction to affect audition, the additive effect of the homologous connexon gene GJB3 were therefore impaired. The complexity of digenic tri-allelic mutations p.V37I/p.L213S/p.V84I in GJB2/GJB3 increased significantly.
According to the genotype-hearing correlation, these tri-allelic mutations might result in increased penetrance of hearing impairment.
Functional evidence with ironic and biochemical studies on CX26/ CX31 heteromeric hemichannels is needed.
F I G U R E 2 Analysis of the p.L213S mutation in GJB2. A, The novel mutation p.L213S in GJB2 was highly conserved among different species. B, The modeled structure shows that p.L213S creates a new hydrogen bond (arrow) with p.E209 compared to wild-type The digenic inheritance in autosomal recessive NSHI caused by mutations in GJB2/GJB3 has been documented in different populations (Table 2) . However, a digenic tri-allelic mutation inheritance for p.V37I/p.L213S/p.V84I in GJB2/GJB3 was never seen, indicating the genetic heterogeneity of NSHI. Given this condition, targeted NGS panel is increasingly used as an alternative to reveal uncommon deafness-associated genes. Examples of this were the successful identifications of rare/novel mutations in PCDH15, MYO7A, CDH23 genes in sporadic families by us and other authors. 6, [20] [21] [22] [23] [24] Hence, it's likely to uncover the hidden genetic etiologies for GJB2 carriers by NGS in future, which could not be achieved in this study owing to economic cost.
TA B L E 2 Digenic GJB2/GJB3 mutations in various populations
Great efforts have been made toward clarifying the contributions of GJB3 and GJB6 mutations to deafness in diverse populations during the past decades. 8, 10, 11, 13, 18, [25] [26] [27] [28] [29] Likewise, a genetic study of 129 Italian NSHI infants for GJB6 and GJB3 genes found no mutation. 28 Similar results were observed in American, 10 Moroccan, 25 and Indian 29 NSHI. The allele frequencies of variants in GJB3 and GJB6 were estimated to be "0-2.78%" 8, 10, 13, [25] [26] [27] [28] and "0%-1.42%" 13, [25] [26] [27] [28] [29] respectively. Our present results, in combination with preceding studies, suggest that the effect of GJB3 and GJB6
in GJB2 carriers may not be predominant. Environmental causes or unknown mutations in other genes are assumed to trigger hearing loss in these patients, who might otherwise be coincidental GJB2 carriers. Advanced genetic tool, such as NGS or whole exome sequencing, may shed new light on the potential candidate genes, in them.
This study has several weaknesses. Apart from the limited numbers in this cohort, we were unable to collect the data of the I:1 and I:2 in this family, who did not prepare to participate in our study, since they "had normal hearing and language ability". Also, the GJB3 p.V84I may be a potential modifier, but the mechanism was not understood yet. For such hypothesis to be verified, it is of utmost importance to verify the extent of gap junction damage at the cellular level by constructing digenic mutations model in vitro and in vivo.
| CON CLUS IONS
GJB3/GJB6 variants account for a low proportion in autosomal recessive GJB2 mutation carriers in our cohort. Environmental causes, or other NSHI relevant genes, revealed by targeted NGS or whole exome sequencing, may play a major role in triggering deafness in these patients.
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